Organigram Holdings Inc. announced on February 28, 2025, the closing of the third and final tranche of its previously announced C$124,559,674 follow-on strategic equity investment from BT DE Investments Inc., a wholly owned subsidiary of British American Tobacco plc (BAT). This completion marks a significant milestone in the company's financial strategy.
This final tranche provides Organigram with additional capital, further strengthening its balance sheet and liquidity. The full investment from BAT underscores a continued strategic partnership, which is crucial for Organigram's long-term growth initiatives and market expansion.
The capital infusion is expected to support Organigram's operational enhancements and strategic objectives, including product innovation and international market penetration. This financing event reinforces the company's ability to execute its business plan with robust financial backing.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.